Skip to main content

Find Clinical Trials

Home
Conditions
Refractory ALK Positive Large B-Cell Lymphoma

Clinical trial condition

Refractory ALK Positive Large B-Cell Lymphoma

Explore clinical trials studying Refractory ALK Positive Large B-Cell Lymphoma. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Refractory ALK Positive Large B-Cell Lymphoma trial results

Active, Not Recruiting

TTI-622 in Combination With Pembrolizumab for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma

NCT05507541

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +36 more
Locations: University of Iowa Iowa City, Iowa, United States

Mayo Clinic Rochester, Minnesota, United States

View Trial Details